Journal profile
ISCC Indonesian Journal of Cancer Chemoprevention
ISSN 2088-0197 · eISSN 2355-8989 · Indonesian Society for Cancer Chemoprevention · Indonesia
ISCC Indonesian Journal of Cancer Chemoprevention: fully open access; APC charged, amount not published; review about 20 weeks (community reports); 13 articles in 2025.
Scope
Aims, scope and focus
ISCC Indonesian Journal of Cancer Chemoprevention is published by Indonesian Society for Cancer Chemoprevention. By OpenAlex counts of its recent articles, its largest topics are Medicinal Plant Research, Phytochemical Studies and Bioactivities and Computational Drug Discovery Methods, together about 52.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Indonesian Journal of Cancer Chemoprevention (IJCC) is an open access, peer-reviewed, triannual journal devoted to publish articles on cancer chemoprevention including Experimental and Clinical Pharmacology, especially concerning anti-oxidants, anti-aging, anti-inflammation, anti-angiogenesis, and anti-carcinogenesis; Cancer Detection; Stem Cell Biology; Immunology; in vitro and in silico Exploration of Chemopreventive Mechanism; and Natural Products. IJCC is an official journal of the Indonesian Society for Cancer Chemoprevention.
From the journal's Aims & Scope
Editor-in-chief Adam HermawanPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named Indonesia 22, Japan 4, United States 3, Germany 2, Mainland China 1 (36 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medicinal Plant ResearchAgricultural and Biological Sciences25.8%
- Phytochemical Studies and BioactivitiesBiochemistry, Genetics and Molecular Biology18.3%
- Computational Drug Discovery MethodsComputer Science8.1%
- Phytochemistry Medicinal Plant ApplicationsAgricultural and Biological Sciences4.8%
- Ginger and Zingiberaceae researchPharmacology, Toxicology and Pharmaceutics4.1%
- Bioactive natural compoundsBiochemistry, Genetics and Molecular Biology3.9%
- Curcumin's Biomedical ApplicationsBiochemistry, Genetics and Molecular Biology3.7%
- Phytochemicals and Antioxidant ActivitiesMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 13OpenAlex ·
- i10-index
- 24OpenAlex ·
- 2-year mean citedness
- 0.55OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 284 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 12 | 12 | 69 |
| 2025 | 13 | 13 | 118 |
| 2024 | 13 | 13 | 174 |
| 2023 | 19 | 19 | 156 |
| 2022 | 16 | 16 | 174 |
| 2021 | 20 | 20 | 185 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 20 weeksLetPub ·
- Peer review
- Double anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| LetPub | No APC | No | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Page charges
- No page charges
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- ≤ 5
- Manuscript length
- ≤ 3,500 words
- Reference style
- Harvard
- Templates
- Word
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
Article types accepted2, with length limits
- research articleResearch Article: Research Article should consist of no more than 3,500 words, not including the words in abstract, references, table, figure, and figure legend…main text ≤ 3,500 words
- review articleview Article: Only for invited authors. Review Article should consist of no more than 10,000 words, not including the words in abstract, references, table, fimain text ≤ 10,000 words
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review, Plagiarism
- AI use Gen AI Policy
Indonesian Journal of Cancer Chemoprevention (IJCC) policy regarding the use of generative AI for publication: 1. Main Principles AI is used only as an aid, for example, to improve writing efficiency, synthesize literature, or improve English, it is not used to replace human critical thinking and evaluation.Authors are fully responsible for their published manuscripts and control the AI-assisted r…
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Policy
Author’s Conflict of Interest At the point of submission, Indonesian Journal of Cancer Chemoprevention requires that each author reveals any personal and/or financial interests or connections, direct or indirect, or other situations that might raise the question of bias in work reported or the conclusions, implications, or opinions stated. When considering whether you should declare a conflicting …
Source ↗Publisher website ·- License & copyright Copyright Notice
For the submission of a manuscript to Indonesian Journal of Cancer Chemoprevention, I hereby certify that: 1. I have been granted authorization by my co-author/s to enter into these arrangements. The manuscript submitted is an original work and has neither been published in any other peer-reviewed journal nor is under consideration for publication by any other journal. More so, the work has been c…
Source ↗Publisher website ·- Open access Open Access Policy
No submission and processing charges Model summary
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, or to use them for any other lawful purpose.
Source ↗Publisher website ·- Peer review Peer Review Process
Peer review Model summary
All manuscripts submitted to Indonesian Journal of Cancer Chemoprevention (IJCC) will be selected and double-blind peer-reviewed by 2 or more reviewers when necessary, to present valuable and authentic findings. All details will also be reviewed, including appropriate title; content reflecting abstract; concise writing; clear purpose, study method and figures and/or tables; and summary supported b…
Source ↗Publisher website ·- Plagiarism Plagiarism Screening Policy
All manuscripts submitted to Indonesian Journal of Cancer Chemoprevention will be screened for plagiarism by using Turnitin and/or Crossref Similarity Check.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Indonesian Society for Cancer Chemoprevention
- Country or region
- Indonesia
- Language
- English
- ISSN
- 2088-0197
- Electronic ISSN
- 2355-8989
- Society / sponsor
- Indonesian Society for Cancer Chemoprevention
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about ISCC Indonesian Journal of Cancer Chemoprevention
How long does peer review take at ISCC Indonesian Journal of Cancer Chemoprevention?
Authors report an average review time of about 20 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of ISCC Indonesian Journal of Cancer Chemoprevention?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: ≤ 5; Manuscript length: ≤ 3,500 words; Reference style: Harvard; Templates: Word; First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of ISCC Indonesian Journal of Cancer Chemoprevention based?
Of the 36 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are Indonesia (22), Japan (4) and United States (3). Counted from the institutions listed on the board page; for reference only.
Is ISCC Indonesian Journal of Cancer Chemoprevention open access, and what is the APC?
ISCC Indonesian Journal of Cancer Chemoprevention is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .